Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Hiv, Swiss Cohort Study"'
Autor:
Au, Scherrer, Wl, Yang, Rd, Kouyos, Böni J, Yerly S, Klimkait T, Aubert V, Cavassini M, Battegay M, Christoph Hauser, Calmy A, Schmid P, Bernasconi E, Hf, Günthard, Hiv, Swiss Cohort Study
Publikováno v:
JOURNAL OF INFECTIOUS DISEASES
The Journal of Infectious Diseases, Vol. 214, No 3 (2016) pp. 399-402
Europe PubMed Central
The Journal of Infectious Diseases, Vol. 214, No 3 (2016) pp. 399-402
Europe PubMed Central
The prevalence of integrase strand transfer inhibitor (INSTI)-transmitted drug resistance (TDR) may increase with the increasing use of INSTIs. We analyzed the prevalence of INSTI TDR in the Swiss HIV Cohort Study (2008-2014). In 1 of 1316 drug-naive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::695e59d518a97d74034e54f8e6d6d244
Autor:
di Iulio J, Fayet A, Arab-Alameddine M, Rotger M, Lubomirov R, Cavassini M, Furrer H, Hf, Günthard, Colombo S, Chantal Csajka, Cb, Eap, La, Decosterd, Telenti A, Hiv, Swiss Cohort Study
Publikováno v:
Pharmacogenetics and genomics
Europe PubMed Central
Europe PubMed Central
INTRODUCTION: The antiretroviral drug efavirenz (EFV) is extensively metabolized into three primary metabolites: 8-hydroxy-EFV, 7-hydroxy-EFV and N-glucuronide-EFV. There is a wide interindividual variability in EFV plasma exposure, explained to a gr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fdc66436aea65146e0ed420508aae030
Autor:
Rauch A, Nolan D, Thurnheer C, Ca, Fux, matthias cavassini, Jp, Chave, Opravil M, Phillips E, Mallal S, Furrer H, Hiv, Swiss Cohort Study
Publikováno v:
Europe PubMed Central
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::f8a8abd27f97b4f0fe1d829597d0622c
https://www.zora.uzh.ch/id/eprint/12001/
https://www.zora.uzh.ch/id/eprint/12001/
Autor:
Simcock M, Sendi P, Ledergerber B, Keller T, Jörg Schüpbach, Battegay M, Hf, Günthard, Hiv, Swiss Cohort Study
Publikováno v:
ResearcherID
Europe PubMed Central
Europe PubMed Central
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::44f81376820eb8e74bcf8e7db777ab57
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000237963400004&KeyUID=WOS:000237963400004
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000237963400004&KeyUID=WOS:000237963400004
Autor:
Nj, Müller, Furrer H, Kaiser L, Hirschel B, Cavassini M, Jacques Fellay, Jp, Chave, Rp, Wüthrich, Weber M, Müllhaupt B, Candinas D, Reichen J, Giostra E, Mentha G, Halkic N, Hh, Hirsch, Weber R, Hiv, Swiss Cohort Study
Publikováno v:
Europe PubMed Central
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::1b6672a563487082575a39392a68cbc4
http://europepmc.org/abstract/med/16633968
http://europepmc.org/abstract/med/16633968
Autor:
Bertisch, B., silvia franceschi, Lise, M., Vernazza, P., Keiser, O., Schöni-Affolter, F., Bouchardy, C., Dehler, S., Levi, F., Jundt, G., Ess, S., Pawlita, M., Kovari, H., Wandeler, G., Calmy, A., Cavassini, M., Stöckle, M., Clifford, G., Hiv, Swiss Cohort Study Investigators
Publikováno v:
Scopus-Elsevier
Bertisch, Barbara; Franceschi, Silvia; Lise, Mauro; Vernazza, Pietro; Keiser, Olivia; Schöni-Affolter, Franziska; Bouchardy, Christine; Dehler, Silvia; Levi, Fabio; Jundt, Gernot; Ess, Silvia; Pawlita, Michael; Kovari, Helen; Wandeler, Gilles; Calmy, Alexandra; Cavassini, Matthias; Stöckle, Marcel; Clifford, Gary (2013). Risk factors for anal cancer in persons infected with HIV: a nested case-control study in the Swiss HIV Cohort Study. American journal of epidemiology, 178(6), pp. 877-884. Oxford University Press 10.1093/aje/kwt153
American Journal of Epidemiology, Vol. 178, No 6 (2013) pp. 877-84
American journal of epidemiology
Bertisch, Barbara; Franceschi, Silvia; Lise, Mauro; Vernazza, Pietro; Keiser, Olivia; Schöni-Affolter, Franziska; Bouchardy, Christine; Dehler, Silvia; Levi, Fabio; Jundt, Gernot; Ess, Silvia; Pawlita, Michael; Kovari, Helen; Wandeler, Gilles; Calmy, Alexandra; Cavassini, Matthias; Stöckle, Marcel; Clifford, Gary (2013). Risk factors for anal cancer in persons infected with HIV: a nested case-control study in the Swiss HIV Cohort Study. American journal of epidemiology, 178(6), pp. 877-884. Oxford University Press 10.1093/aje/kwt153
American Journal of Epidemiology, Vol. 178, No 6 (2013) pp. 877-84
American journal of epidemiology
Anal cancer is common among people infected with human immunodeficiency virus (HIV). This cancer is caused by human papillomavirus, and immunosuppression likely contributes to its development. In this issue of the Journal, Bertisch et al. (Am J Epide
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27a01309ff029f74e93292b633dc68ae
http://www.scopus.com/inward/record.url?eid=2-s2.0-84887396930&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-84887396930&partnerID=MN8TOARS
Autor:
Arab-Alameddine M, Lubomirov R, Fayet-Mello A, Aouri M, Rotger M, Buclin T, Widmer N, Gatri M, Ledergerber B, Rentsch K, Cavassini M, Panchaud A, Guidi M, Telenti A, La, Décosterd, Chantal Csajka, Hiv, Swiss Cohort Study
Publikováno v:
Europe PubMed Central
Journal of Antimicrobial Chemotherapy, vol. 69, no. 9, pp. 2489-2498
Journal of Antimicrobial Chemotherapy, vol. 69, no. 9, pp. 2489-2498
OBJECTIVES: Darunavir is a protease inhibitor that is administered with low-dose ritonavir to enhance its bioavailability. It is prescribed at standard dosage regimens of 600/100 mg twice daily in treatment-experienced patients and 800/100 mg once da
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8fccbec2b3e55c7da3a3350e1b86a122
http://europepmc.org/abstract/med/24821595
http://europepmc.org/abstract/med/24821595
Autor:
Rotger, Margalida, Colombo, Sara, Furrer, Hansjakob, Laurent Decosterd, Buclin, Thierry, Telenti, Amalio, Hiv, Swiss Cohort Study
Publikováno v:
ResearcherID
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::47d69da82669ed6a9a35563dce03f082
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000247111200015&KeyUID=WOS:000247111200015
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000247111200015&KeyUID=WOS:000247111200015
Autor:
Arab-Alameddine M, Fayet-Mello A, Lubomirov R, Neely M, di Iulio J, Owen A, Boffito M, Cavassini M, Hf, Günthard, Rentsch K, Buclin T, Aouri M, Telenti A, La, Decosterd, Rotger M, Chantal Csajka, Hiv, Swiss Cohort Study Group
Publikováno v:
Europe PubMed Central
Antimicrobial agents and chemotherapy
Antimicrobial agents and chemotherapy
The objectives of this study were to characterize raltegravir (RAL) population pharmacokinetics in HIV-positive (HIV + ) and healthy individuals, identify influential factors, and search for new candidate genes involved in UDP glucuronosyltransferase
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae78ee0ea4ceea40912236bb04eb022a
http://europepmc.org/abstract/med/22371894
http://europepmc.org/abstract/med/22371894
Autor:
Gr, Kaufmann, Khanna N, Weber R, Perrin L, Furrer H, matthias cavassini, Ledergerber B, Vernazza P, Bernasconi E, Rickenbach M, Hirschel B, Battegay M, Hiv, Swiss Cohort Study
Publikováno v:
Europe PubMed Central
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::61162444935cd56e49223912bcd975d3
http://europepmc.org/abstract/med/15134189
http://europepmc.org/abstract/med/15134189